BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O’leary JG, Greenberg CS, Patton HM, Caldwell SH. AGA Clinical Practice Update: Coagulation in Cirrhosis. Gastroenterology 2019;157:34-43.e1. [DOI: 10.1053/j.gastro.2019.03.070] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 27.0] [Reference Citation Analysis]
Number Citing Articles
1 Sripongpun P, Pongpaibul A, Charatcharoenwitthaya P. Value and risk of percutaneous liver biopsy in patients with cirrhosis and clinical suspicion of autoimmune hepatitis. BMJ Open Gastroenterol 2021;8:e000701. [PMID: 34362759 DOI: 10.1136/bmjgast-2021-000701] [Reference Citation Analysis]
2 Brown RS Jr, Imawari M, Izumi N, Osaki Y, Bentley R, Ochiai T, Kano T, Peck-Radosavljevic M. Assessing the periprocedural magnitude of platelet count change in response to lusutrombopag. JHEP Rep 2021;3:100228. [PMID: 33644726 DOI: 10.1016/j.jhepr.2021.100228] [Reference Citation Analysis]
3 Li X, Wu S, Yu Y. Aspirin Use and the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis of Cohort Studies. Front Med (Lausanne) 2020;7:569759. [PMID: 33490093 DOI: 10.3389/fmed.2020.569759] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kim A, Niu B, Woreta T, Chen PH. Clinical Considerations of Coagulopathy in Acute Liver Failure. J Clin Transl Hepatol 2020;8:407-13. [PMID: 33447524 DOI: 10.14218/JCTH.2020.00058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Kulkarni AV, Rabiee A, Mohanty A. Management of Portal Hypertension. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.03.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tosetti G, Primignani M. Author's reply: "Staging the pre-procedural prophylaxis in decompensated cirrhosis". Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2022.05.003] [Reference Citation Analysis]
7 O'Leary JG. Portal Vein Thrombosis Prediction: Rebalanced Coagulation and Rethinking Anticoagulation. Liver Transpl 2019;25:1741-2. [PMID: 31609543 DOI: 10.1002/lt.25661] [Reference Citation Analysis]
8 Perez I, Bolte FJ, Bigelow W, Dickson Z, Shah NL. Step by Step: Managing the Complications of Cirrhosis. Hepat Med 2021;13:45-57. [PMID: 34079394 DOI: 10.2147/HMER.S278032] [Reference Citation Analysis]
9 von Meijenfeldt FA, van den Boom BP, Adelmeijer J, Roberts LN, Lisman T, Bernal W. Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease. J Thromb Haemost 2021;19:664-76. [PMID: 33219597 DOI: 10.1111/jth.15185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Jadaun SS, Saigal S. Surgical Risk Assessment in Patients With Chronic Liver Diseases. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.03.004] [Reference Citation Analysis]
11 Lisman T, Intagliata NM. Bleeding and Thrombosis in Patients with Liver Diseases. Semin Thromb Hemost 2020;46:653-5. [PMID: 32932541 DOI: 10.1055/s-0040-1715453] [Reference Citation Analysis]
12 Rose PD, Au M, Woodman RJ, Tee D, Chinnaratha MA. Pre-procedural use of thrombopoietin-receptor agonists in cirrhosis and severe thrombocytopenia: A systematic review and meta-analysis. Dig Liver Dis 2021:S1590-8658(21)00384-4. [PMID: 34373229 DOI: 10.1016/j.dld.2021.07.015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 O'Shea RS, Davitkov P, Ko CW, Rajasekhar A, Su GL, Sultan S, Allen AM, Falck-Ytter Y. AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis. Gastroenterology 2021;161:1615-1627.e1. [PMID: 34579936 DOI: 10.1053/j.gastro.2021.08.015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Khalifa A, Rockey DC. Lower Gastrointestinal Bleeding in Patients With Cirrhosis-Etiology and Outcomes. Am J Med Sci 2020;359:206-11. [PMID: 32087941 DOI: 10.1016/j.amjms.2020.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Rawi S, Wu GY. Pathogenesis of Thrombocytopenia in Chronic HCV Infection: A Review. J Clin Transl Hepatol 2020;8:184-91. [PMID: 32832399 DOI: 10.14218/JCTH.2020.00007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
16 Stotts MJ, Davis JPE, Shah NL. Coagulation testing and management in liver disease patients. Curr Opin Gastroenterol 2020;36:169-76. [PMID: 32141899 DOI: 10.1097/MOG.0000000000000635] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Blasi A, Cardenas A. Invasive Procedures in Patients with Cirrhosis: A Clinical Approach Based on Current Evidence. Clin Liver Dis 2021;25:461-70. [PMID: 33838861 DOI: 10.1016/j.cld.2021.02.001] [Reference Citation Analysis]
18 Roberts LN. Rebalanced hemostasis in liver disease: a misunderstood coagulopathy. Hematology Am Soc Hematol Educ Program 2021;2021:485-91. [PMID: 34889414 DOI: 10.1182/hematology.2021000283] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Al Moosawi M, Trudeau J, Smith T, Lefebvre A, Shih AW. ROTEM in the setting of liver transplant surgery reduces frozen plasma transfusion. Transfus Apher Sci 2021;60:103125. [PMID: 33775554 DOI: 10.1016/j.transci.2021.103125] [Reference Citation Analysis]
20 Fortea JI, Carrera IG, Puente Á, Cuadrado A, Huelin P, Tato CÁ, Fernández PÁ, Montes MDRP, Céspedes JN, López AB, Sanchez FJG, Hoyos ML, Crespo J, Fábrega E. Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders. J Clin Med 2020;9:E2822. [PMID: 32878264 DOI: 10.3390/jcm9092822] [Reference Citation Analysis]
21 Yang H, Mou Y, Hu B. Safety and efficacy of common endoscopic treatments in patients with decompensated liver cirrhosis. Ann Hepatol 2022;27:100689. [PMID: 35192965 DOI: 10.1016/j.aohep.2022.100689] [Reference Citation Analysis]
22 Caldwell S, Carlini LE. Coagulation Homeostasis in Liver Disease. Clin Liver Dis (Hoboken) 2020;16:137-41. [PMID: 33163164 DOI: 10.1002/cld.935] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Rocha LL, Corrêa TD. Reply to "Comment on 'Comparison of three transfusion protocols prior to central venous catheterization in patients with cirrhosis; a randomized controlled trial'". J Thromb Haemost 2020;18:754-5. [PMID: 32112528 DOI: 10.1111/jth.14737] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Semmler G, Pomej K, Bauer DJM, Balcar L, Simbrunner B, Binter T, Hartl L, Becker J, Pinter M, Quehenberger P, Trauner M, Mandorfer M, Lisman T, Reiberger T, Scheiner B. Safety of direct oral anticoagulants in patients with advanced liver disease. Liver Int 2021;41:2159-70. [PMID: 34152697 DOI: 10.1111/liv.14992] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Martinez S, Garcia I, Ruiz A, Tàssies D, Reverter JC, Colmenero J, Beltran J, Fondevila C, Blasi A. Is antivitamin K reversal required in patients with cirrhosis undergoing liver transplantation? Transfusion 2021. [PMID: 34358342 DOI: 10.1111/trf.16607] [Reference Citation Analysis]
26 Zia HA, Aby ES, Rabiee A. An Update on the Management of Esophageal Variceal Hemorrhage. Clin Liver Dis (Hoboken) 2021;18:179-83. [PMID: 34745574 DOI: 10.1002/cld.1108] [Reference Citation Analysis]
27 Zhang X, Han J, Qi X, Zhang Y, Zhou P, Liu X, Ying Y, Zhang W, Zhang J, Huang Y. DIC Score Combined With CLIF-C OF Score Is More Effective in Predicting Prognosis in Patients With Hepatitis B Virus Acute-on-Chronic Liver Failure. Front Med 2022;9:815580. [DOI: 10.3389/fmed.2022.815580] [Reference Citation Analysis]
28 Gupta P, Kalra N, Keshava SN, Chaluvashetty SB, Mukund A, Roy-choudhury SH, Baijal SS, Khandelwal A, Ananthashayana VH, R. SN, Kulkarni S, Shetty NS, Gupta A, Gupta S. Indian Society of Vascular and Interventional Radiology Expert Consensus Statements for Ablation in Hepatocellular Carcinoma: Part I. Journal of Clinical Interventional Radiology ISVIR 2020;4:098-106. [DOI: 10.1055/s-0040-1715774] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
29 Martin Mateos R, Maddur H. A step forward to accurately predict mortality in cirrhotic patients undergoing elective surgery: The role of the hepatic venous pressure gradient. J Hepatol 2019;71:862-3. [PMID: 31558289 DOI: 10.1016/j.jhep.2019.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Serrano Zarcero V, Benítez Linero I, Bastón Castiñéiras M, León Herrera J, López Romero JL. Case Report of a Patient Treated With Acenocumarol Awaiting Orthotopic Liver Transplant: Perioperative Coagulation Management and Risk for Hepatic Artery Thrombosis. Transplant Proc 2021:S0041-1345(21)00817-4. [PMID: 34895900 DOI: 10.1016/j.transproceed.2021.10.012] [Reference Citation Analysis]
31 von Meijenfeldt FA, Lisman T. Fibrinolysis in Patients with Liver Disease. Semin Thromb Hemost 2021;47:601-9. [PMID: 33772480 DOI: 10.1055/s-0040-1718924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Bihari C, Patil A, Shasthry SM, Baweja S, Kumar G, Sarin SK. Viscoelastic test-based bleeding risk score reliably predicts coagulopathic bleeding in decompensated cirrhosis and ACLF patients. Hepatol Int 2020;14:597-608. [PMID: 32304090 DOI: 10.1007/s12072-020-10036-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 He Y, Yuan S, Guo X, Yi F, Xu X, An Y, Xu S, Ageno W, Qi X. Association of thromboelastography profile with severity of liver cirrhosis and portal venous system thrombosis. BMC Gastroenterol 2021;21:253. [PMID: 34098892 DOI: 10.1186/s12876-021-01832-3] [Reference Citation Analysis]
34 Galante A, De Gottardi A. Portal vein thrombosis: an overview of current treatment options. Acta Gastroenterol Belg 2021;84:327-32. [PMID: 34217184 DOI: 10.51821/84.2.327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Lisman T, Hernandez-Gea V, Magnusson M, Roberts L, Stanworth S, Thachil J, Tripodi A. The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease. J Thromb Haemost 2021;19:1116-22. [PMID: 33792172 DOI: 10.1111/jth.15239] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
36 McMurry HS, Jou J, Shatzel J. The hemostatic and thrombotic complications of liver disease. Eur J Haematol 2021. [PMID: 34258797 DOI: 10.1111/ejh.13688] [Reference Citation Analysis]
37 Shenoy A, Louissaint J, Shannon C, Tapper EB, Lok AS. Viscoelastic Testing Prior to Non-surgical Procedures Reduces Blood Product Use Without Increasing Bleeding Risk in Cirrhosis. Dig Dis Sci 2022. [PMID: 35122595 DOI: 10.1007/s10620-021-07376-6] [Reference Citation Analysis]
38 Ciavarella A, Gnocchi D, Custodero C, Lenato GM, Fiore G, Sabbà C, Mazzocca A. Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease. Thromb Res 2021;198:139-50. [PMID: 33340925 DOI: 10.1016/j.thromres.2020.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
39 Zhang Y, Xu BY, Wang XB, Zheng X, Huang Y, Chen J, Meng ZJ, Gao YH, Qian ZP, Liu F, Lu XB, Shi Y, Shang J, Li H, Wang SY, Yin S, Sun SN, Hou YX, Xiong Y, Chen J, Li BL, Lei Q, Gao N, Ji LJ, Li J, Jie FR, Zhao RH, Liu JP, Lin TF, Chen LY, Tan WT, Zhang Q, Zou CC, Huang ZB, Jiang XH, Luo S, Liu CY, Zhang YY, Li T, Ren HT, Wang SJ, Deng GH, Xiong SE, Liu XX, Wang C, Yuan W, Gu WY, Qiao L, Wang TY, Wu DD, Dong FC, Li H, Hua J. Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute Decompensation. Clin Gastroenterol Hepatol 2020;18:2564-2572.e1. [PMID: 32109631 DOI: 10.1016/j.cgh.2020.02.037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
40 Roberts LN, Bernal W. Incidence of Bleeding and Thrombosis in Patients with Liver Disease. Semin Thromb Hemost 2020;46:656-64. [PMID: 32757184 DOI: 10.1055/s-0040-1714205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
41 Huang J, Yin X, Zhang L, Yao M, Wei D, Wu Y. Serum proteomic profiling in patients with advanced Schistosoma japonicum-induced hepatic fibrosis. Parasit Vectors 2021;14:232. [PMID: 33933138 DOI: 10.1186/s13071-021-04734-1] [Reference Citation Analysis]
42 Curry B, Mueller S, MacLaren R. The Use of Prothrombin Complex Concentrates: Results of a Nationwide Survey of Critical Care Pharmacists. J Pharm Pract 2022;35:197-204. [PMID: 35484869 DOI: 10.1177/0897190020966184] [Reference Citation Analysis]
43 Aluizio CLS, Montes CG, Reis GFSR, Nagasako CK. Risk stratification in acute variceal bleeding: Far from an ideal score. Clinics (Sao Paulo) 2021;76:e2921. [PMID: 34190855 DOI: 10.6061/clinics/2021/e2921] [Reference Citation Analysis]
44 Tosetti G, Farina E, Caccia R, Sorge A, Berzuini A, Valenti L, Prati D, Tripodi A, Lampertico P, Primignani M. Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian association for the study of the liver (AISF). Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2022.03.017] [Reference Citation Analysis]
45 Czajka P, Przybyłkowski A, Nowak A, Postula M, Wolska M, Mirowska-Guzel D, Czlonkowska A, Eyileten C. Antiplatelet drugs and liver fibrosis. Platelets 2021;:1-10. [PMID: 33577391 DOI: 10.1080/09537104.2021.1883574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Pomej K, Scheiner B, Park D, Bauer D, Balcar L, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M. Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Cancers (Basel) 2020;12:E2961. [PMID: 33066190 DOI: 10.3390/cancers12102961] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
47 Crighton GL, Huisman EJ. Pediatric Fibrinogen PART II-Overview of Indications for Fibrinogen Use in Critically Ill Children. Front Pediatr 2021;9:647680. [PMID: 33968851 DOI: 10.3389/fped.2021.647680] [Reference Citation Analysis]
48 Meng Y, Sun J, Zheng Y, Zhang G, Yu T, Piao H. Platelets: The Emerging Clinical Diagnostics and Therapy Selection of Cancer Liquid Biopsies. Onco Targets Ther 2021;14:3417-28. [PMID: 34079287 DOI: 10.2147/OTT.S311907] [Reference Citation Analysis]
49 Ostojic Z, Ostojic A, Bulum J, Mrzljak A. Safety and efficacy of dual antiplatelet therapy after percutaneous coronary interventions in patients with end-stage liver disease. World J Cardiol 2021; 13(11): 599-607 [PMID: 34909126 DOI: 10.4330/wjc.v13.i11.599] [Reference Citation Analysis]
50 Northup PG, Lisman T, Roberts LN. Treatment of bleeding in patients with liver disease. J Thromb Haemost 2021;19:1644-52. [PMID: 33974330 DOI: 10.1111/jth.15364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Lisman T, Procopet B. Fresh frozen plasma in treating acute variceal bleeding: Not effective and likely harmful. Liver Int 2021;41:1710-2. [PMID: 34273225 DOI: 10.1111/liv.14988] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 He Y, Yuan S, Guo X, Yi F, Xu X, An Y, Xu S, Ageno W, Qi X. Association of thromboelastography profile with severity of liver cirrhosis and portal venous system thrombosis. BMC Gastroenterol 2021;21:253. [PMID: 34098892 DOI: 10.1186/s12876-021-01832-3] [Reference Citation Analysis]
53 Lamarche MC, Alrajhi E, Wells PS. Direct oral anticoagulant use in special populations. Curr Opin Pulm Med 2021;27:311-8. [PMID: 34115699 DOI: 10.1097/MCP.0000000000000787] [Reference Citation Analysis]
54 Thomes PG, Rasineni K, Saraswathi V, Kharbanda KK, Clemens DL, Sweeney SA, Kubik JL, Donohue TM Jr, Casey CA. Natural Recovery by the Liver and Other Organs after Chronic Alcohol Use. Alcohol Res 2021;41:05. [PMID: 33868869 DOI: 10.35946/arcr.v41.1.05] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Lucas F, Stecker MS, Pozdnyakova O, Connors JM, Battinelli EM. Rivaroxaban-calibrated chromogenic anti-Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulation. Res Pract Thromb Haemost 2021;5:e12594. [PMID: 34646974 DOI: 10.1002/rth2.12594] [Reference Citation Analysis]
56 Mann JP, Carter P, Armstrong MJ, Abdelaziz HK, Uppal H, Patel B, Chandran S, More R, Newsome PN, Potluri R. Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors. PLoS One. 2020;15:e0241357. [PMID: 33108366 DOI: 10.1371/journal.pone.0241357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Hansen JD, Perri RE, Riess ML. Liver and Biliary Disease of Pregnancy and Anesthetic Implications: A Review. Anesth Analg 2021;133:80-92. [PMID: 33687174 DOI: 10.1213/ANE.0000000000005433] [Reference Citation Analysis]
58 Lei F, Liu YM, Zhou F, Qin JJ, Huang X, Zhang BH, Li H, Yuan Y. REPLY. Hepatology 2021;73:470-1. [PMID: 32614976 DOI: 10.1002/hep.31449] [Reference Citation Analysis]
59 Tavares MF, DeMarinis S, Cheves TA, Sweeney JD. Elevated INR in the ICU and plasma transfusion. Transfusion 2022;62:508-10. [PMID: 35146765 DOI: 10.1111/trf.16779] [Reference Citation Analysis]
60 Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:366-413. [PMID: 33219529 DOI: 10.1002/hep.31646] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 28.0] [Reference Citation Analysis]
61 Shenoy A, Intagliata NM. Thromboelastography and Utility in Hepatology Practice. Clin Liver Dis (Hoboken). 2020;16:149-152. [PMID: 33163167 DOI: 10.1002/cld.947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Mücke MM, Miesbach W, Peiffer KH, Mücke VT, Bojunga J. [Management of hemostasis in gastroenterology critical care]. Z Gastroenterol 2020;58:1099-106. [PMID: 33197951 DOI: 10.1055/a-1246-3423] [Reference Citation Analysis]
63 Driever EG, Lisman T. Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease. Semin Thromb Hemost 2022. [PMID: 35135033 DOI: 10.1055/s-0042-1742438] [Reference Citation Analysis]
64 Kasper P, Tacke F, Michels G. [Management of acutely decompensated liver cirrhosis in emergency and critical care medicine]. Anaesthesist 2022. [PMID: 35357555 DOI: 10.1007/s00101-022-01113-y] [Reference Citation Analysis]
65 Leal-Noval SR, Fernández Pacheco J, Casado Méndez M, Cuenca-Apolo D, Múñoz-Gómez M. Current perspective on fibrinogen concentrate in critical bleeding. Expert Rev Clin Pharmacol 2020;13:761-78. [PMID: 32479129 DOI: 10.1080/17512433.2020.1776608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Miranda-Zazueta G, León-Garduño LAP, Aguirre-Valadez J, Torre-Delgadillo A. Bacterial infections in cirrhosis: Current treatment. Ann Hepatol 2020;19:238-44. [PMID: 32317149 DOI: 10.1016/j.aohep.2019.09.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Neuberger J, Patel J, Caldwell H, Davies S, Hebditch V, Hollywood C, Hubscher S, Karkhanis S, Lester W, Roslund N, West R, Wyatt JI, Heydtmann M. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut 2020;69:1382-403. [PMID: 32467090 DOI: 10.1136/gutjnl-2020-321299] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
68 Janko N, Majeed A, Commins I, Kemp W, Roberts SK. Procedural bleeding risk, rather than conventional coagulation tests, predicts procedure related bleeding in cirrhosis. Eur J Gastroenterol Hepatol 2022;34:192-9. [PMID: 32976185 DOI: 10.1097/MEG.0000000000001948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
69 Ye Y, Li X, Zhu L, Yang C, Tan YW. Establishment of a risk assessment score for deep vein thrombosis after artificial liver support system treatment. World J Clin Cases 2021; 9(31): 9406-9416 [PMID: 34877276 DOI: 10.12998/wjcc.v9.i31.9406] [Reference Citation Analysis]
70 Ballestri S, Capitelli M, Fontana MC, Arioli D, Romagnoli E, Graziosi C, Lonardo A, Marietta M, Dentali F, Cioni G. Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review. Adv Ther 2020;37:1910-32. [PMID: 32285340 DOI: 10.1007/s12325-020-01307-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
71 Roberts LN, Lisman T, Stanworth S, Hernandez-Gea V, Magnusson M, Tripodi A, Thachil J. Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH. J Thromb Haemost 2021. [PMID: 34661370 DOI: 10.1111/jth.15562] [Reference Citation Analysis]
72 Lisman T, Caldwell SH, Intagliata NM. Haemostatic alterations and management of haemostasis in patients with cirrhosis. J Hepatol 2022;76:1291-305. [PMID: 35589251 DOI: 10.1016/j.jhep.2021.11.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Kim TH, Kim SY, Jung YK, Yim HJ, Jung J, Seo W. FIB-4 index and liver fibrosis are risk factors for long-term outcomes in atrial fibrillation-related stroke. Clinical Neurology and Neurosurgery 2022. [DOI: 10.1016/j.clineuro.2022.107235] [Reference Citation Analysis]
74 Scharf RE. Thrombocytopenia and Hemostatic Changes in Acute and Chronic Liver Disease: Pathophysiology, Clinical and Laboratory Features, and Management. J Clin Med 2021;10:1530. [PMID: 33917431 DOI: 10.3390/jcm10071530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Yoshiji H, Ueno Y, Kurosaki M, Torimura T, Hatano E, Yatsuhashi H, Yamakado K. Treatment algorithm for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures. Hepatol Res 2021;51:1181-95. [PMID: 34555262 DOI: 10.1111/hepr.13715] [Reference Citation Analysis]
76 Nguyen G, Lejeune M, Crichi B, Frere C. Hemostasis testing in patients with liver dysfunction: Advantages and caveats. World J Gastroenterol 2021; 27(42): 7285-7298 [PMID: 34876789 DOI: 10.3748/wjg.v27.i42.7285] [Reference Citation Analysis]
77 Dieterich DT, Bernstein D, Flamm S, Pockros PJ, Reau N. Review article: a treatment algorithm for patients with chronic liver disease and severe thrombocytopenia undergoing elective medical procedures in the United States. Aliment Pharmacol Ther 2020;52:1311-22. [PMID: 32813292 DOI: 10.1111/apt.16044] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Nicoară-Farcău O, Soy G, Magaz M, Baiges A, Turon F, Garcia-Criado A, Barrufet M, Burrel M, Hernández-Gea V, García-Pagán JC. New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis. Semin Thromb Hemost 2020;46:673-81. [PMID: 32820481 DOI: 10.1055/s-0040-1715473] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
79 Yen CC, Wang CK, Chaou CH, Chen SY, Lin JP, Ng CJ. Anticoagulant Therapy Is Associated With Decreased Long-Term Mortality in Splenic Infarction Patients: A Multicenter Study. Front Med (Lausanne) 2021;8:778198. [PMID: 34912831 DOI: 10.3389/fmed.2021.778198] [Reference Citation Analysis]
80 Roberts LN, Arya R, Hogan BJ. Comment on Comparison of three transfusion protocols prior to central venous catheterisation in patients with cirrhosis; a randomised controlled trial. J Thromb Haemost 2020;18:753-4. [PMID: 32112529 DOI: 10.1111/jth.14732] [Reference Citation Analysis]
81 van Dievoet MA, Eeckhoudt S, Stephenne X. Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade? Int J Mol Sci 2020;21:E3294. [PMID: 32384725 DOI: 10.3390/ijms21093294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Khemichian S, Terrault NA. Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease. Semin Thromb Hemost. 2020;46:682-692. [PMID: 32820479 DOI: 10.1055/s-0040-1715451] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
83 Kasper P, Tacke F, Michels G. [Management of acutely decompensated liver cirrhosis in emergency and critical care medicine]. Med Klin Intensivmed Notfmed 2021. [PMID: 34636958 DOI: 10.1007/s00063-021-00876-3] [Reference Citation Analysis]
84 Petrisor A, Stanescu AMA, Papacocea IR, Panaitescu E, Peagu R, Moldoveanu AC, Fierbinteanu-Braticevici C. Non-invasive laboratory, imaging and elastography markers in predicting varices with high risk of bleeding in cirrhotic patients. Rom J Intern Med 2021;59:194-200. [PMID: 33544557 DOI: 10.2478/rjim-2021-0001] [Reference Citation Analysis]
85 Neuenfeldt FS, Weigand MA, Fischer D. Coagulopathies in Intensive Care Medicine: Balancing Act between Thrombosis and Bleeding. J Clin Med 2021;10:5369. [PMID: 34830667 DOI: 10.3390/jcm10225369] [Reference Citation Analysis]
86 Oh H, Park HE, Song MS, Kim H, Baek J. The Therapeutic Potential of Anticoagulation in Organ Fibrosis. Front Med 2022;9:866746. [DOI: 10.3389/fmed.2022.866746] [Reference Citation Analysis]
87 Yeoh SW, Kok HK. Transjugular intrahepatic portosystemic shunts in portal vein thrombosis: A review. J Dig Dis 2021. [PMID: 34323378 DOI: 10.1111/1751-2980.13035] [Reference Citation Analysis]
88 Liu P, Hum J, Jou J, Scanlan RM, Shatzel J. Transfusion strategies in patients with cirrhosis. Eur J Haematol 2020;104:15-25. [PMID: 31661175 DOI: 10.1111/ejh.13342] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
89 Pfrepper C, Herber A, Weimann A, Siegemund R, Engelmann C, Aehling N, Seehofer D, Berg T, Petros S. Safety and efficacy of direct oral anticoagulants under long-term immunosuppressive therapy after liver, kidney and pancreas transplantation. Transpl Int 2021;34:423-35. [PMID: 33336411 DOI: 10.1111/tri.13804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Wu WY, Kong DR. Advances in diagnosis and treatment of portal venous thrombosis. Shijie Huaren Xiaohua Zazhi 2021; 29(4): 165-173 [DOI: 10.11569/wcjd.v29.i4.165] [Reference Citation Analysis]
91 Rugivarodom M, Charatcharoenwitthaya P. Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis. J Clin Transl Hepatol 2020;8:432-44. [PMID: 33447527 DOI: 10.14218/JCTH.2020.00067] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Lv Y, Bai W, Li K, Wang Z, Guo W, Luo B, Wang J, Wang Q, Wang E, Xia D, Li X, Yuan J, Han N, Niu J, Yin Z, Fan D, Han G. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study. Am J Gastroenterol 2021;116:1447-64. [PMID: 33630766 DOI: 10.14309/ajg.0000000000001194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
93 Kovalic AJ, Majeed CN, Samji NS, Thuluvath PJ, Satapathy SK. Systematic review with meta-analysis: abnormalities in the international normalised ratio do not correlate with periprocedural bleeding events among patients with cirrhosis. Aliment Pharmacol Ther 2020;52:1298-310. [DOI: 10.1111/apt.16078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
94 van der Heijden WA, Wan J, Van de Wijer L, Jaeger M, Netea MG, van der Ven AJ, de Groot PG, Roest M, de Mast Q. Plasmatic Coagulation Capacity Correlates With Inflammation and Abacavir Use During Chronic HIV Infection. J Acquir Immune Defic Syndr 2021;87:711-9. [PMID: 33492017 DOI: 10.1097/QAI.0000000000002633] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Giannini EG, Kano T, Ochiai T, Bentley R, Shrestha P, Afdhal N. Bleeding events in lusutrombopag-treated thrombocytopenic patients. Eur J Clin Invest 2021;51:e13503. [PMID: 33523482 DOI: 10.1111/eci.13503] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
96 Blasi A, Machlab S, Risco R, Costa-Freixas JP, Hernández-Cely G, Horta D, Bofill A, Ruiz-Ramirez P, Profitos J, Sanahuja JM, Fernandez-Simon A, Gómez MV, Sánchez-Delgado J, Cardenas A. A multicenter analysis of the role of prophylactic transfusion of blood products in patients with cirrhosis and esophageal varices undergoing endoscopic band ligation. JHEP Rep 2021;3:100363. [PMID: 34765959 DOI: 10.1016/j.jhepr.2021.100363] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
97 Tarasconi A, Perrone G, Davies J, Coimbra R, Moore E, Azzaroli F, Abongwa H, De Simone B, Gallo G, Rossi G, Abu-Zidan F, Agnoletti V, de'Angelis G, de'Angelis N, Ansaloni L, Baiocchi GL, Carcoforo P, Ceresoli M, Chichom-Mefire A, Di Saverio S, Gaiani F, Giuffrida M, Hecker A, Inaba K, Kelly M, Kirkpatrick A, Kluger Y, Leppäniemi A, Litvin A, Ordoñez C, Pattonieri V, Peitzman A, Pikoulis M, Sakakushev B, Sartelli M, Shelat V, Tan E, Testini M, Velmahos G, Wani I, Weber D, Biffl W, Coccolini F, Catena F. Anorectal emergencies: WSES-AAST guidelines. World J Emerg Surg 2021;16:48. [PMID: 34530908 DOI: 10.1186/s13017-021-00384-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
98 Chen Z, Ran T, Cao H, Xu F, Zhou ZH, He S. The Impact of Portal Vein Thrombosis on the Prognosis of Patients With Cirrhosis: A Retrospective Propensity-Score Matched Study. Front Med (Lausanne) 2021;8:685944. [PMID: 34262917 DOI: 10.3389/fmed.2021.685944] [Reference Citation Analysis]
99 Kakar N, Daniel G, Fellman C, de Laforcade A, Webster CR. Thromboelastography in cats with cholestatic liver disease. J Feline Med Surg 2021;23:160-7. [PMID: 32672497 DOI: 10.1177/1098612X20939828] [Reference Citation Analysis]
100 Martens K, McMurry HS, Koprowski S, Hum J, Haraga J, Jou JH, Shatzel JJ. Anticoagulation in Cirrhosis: Evidence for the Treatment of Portal Vein Thrombosis and Applications for Prophylactic Therapy. J Clin Gastroenterol 2022. [PMID: 35537133 DOI: 10.1097/MCG.0000000000001713] [Reference Citation Analysis]
101 Wadsworth D, Sullivan E, Jacky T, Sprague T, Feinman H, Kim J. A review of indications and comorbidities in which warfarin may be the preferred oral anticoagulant. J Clin Pharm Ther 2021;46:560-70. [PMID: 33393699 DOI: 10.1111/jcpt.13343] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 He S, Liang C, Yi C, Wu M. Therapeutic effect of continuous diffusion of oxygen therapy combined with traditional moist wound dressing therapy in the treatment of diabetic foot ulcers. Diabetes Res Clin Pract 2021;174:108743. [PMID: 33713718 DOI: 10.1016/j.diabres.2021.108743] [Reference Citation Analysis]
103 Mohanty A, Kapuria D, Canakis A, Lin H, Amat MJ, Rangel Paniz G, Placone NT, Thomasson R, Roy H, Chak E, Baffy G, Curry MP, Laine L, Rustagi T. Fresh frozen plasma transfusion in acute variceal haemorrhage: Results from a multicentre cohort study. Liver Int 2021;41:1901-8. [PMID: 33969607 DOI: 10.1111/liv.14936] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
104 Adam EH, Fischer D. Plasma Transfusion Practice in Adult Surgical Patients: Systematic Review of the Literature. Transfus Med Hemother 2020;47:347-59. [PMID: 33173453 DOI: 10.1159/000511271] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
105 Hsu LI, Chen JW, Lin DT, Wei ST, Hou SM. The continued decline of plasma transfusions in Taiwan: An 11-year population-based study. Vox Sang 2021. [PMID: 34905221 DOI: 10.1111/vox.13222] [Reference Citation Analysis]
106 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu., European Association for the Study of the Liver. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J Hepatol 2022:S0168-8278(21)02033-X. [PMID: 35300861 DOI: 10.1016/j.jhep.2021.09.003] [Reference Citation Analysis]
107 Luther J, Friedman LS. Management of Thrombocytopenia and Coagulopathy in Patients with Chronic Liver Disease Undergoing Therapeutic Endoscopic Interventions. Clin Liver Dis 2022;26:1-12. [PMID: 34802655 DOI: 10.1016/j.cld.2021.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Blasi A, Patel VC, Spanke ENHE, Adelmeijer J, Stamouli M, Zamalloa A, Corcoran E, Calvo A, Fernandez J, Bernal W, Lisman T. Fibrin clot quality in acutely ill cirrhosis patients: Relation with outcome and improvement with coagulation factor concentrates. Liver Int 2021. [PMID: 34894081 DOI: 10.1111/liv.15132] [Reference Citation Analysis]
109 Velarde-Ruiz Velasco JA, García-Jiménez ES, Aldana-Ledesma JM, Tapia-Calderón DK, Tornel-Avelar AI, Lazcano-Becerra M, Chávez-Ramírez RM, Cano-Contreras AD, Remes-Troche JM, Colunga-Lozano LE, Montaño-Loza A. Evaluation and management of emergencies in the patient with cirrhosis. Rev Gastroenterol Mex (Engl Ed) 2022:S2255-534X(22)00029-9. [PMID: 35570104 DOI: 10.1016/j.rgmxen.2022.05.001] [Reference Citation Analysis]